4682-36-4Cc1ccccc1C(OCC[NH+](C)C)c1ccccc1.O=C([O-])CC(O)(CC(=O)O)C(=O)OMMMNTDFSPSQXJP-UHFFFAOYSA-NSee also: Orphenadrine Citrate (preferred); Orphenadrine (has active moiety); Aspirin; caffeine; orphenadrine citrate (component of).
化学的特性White Solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
使用Muscle relaxant (skeletal); antihistaminic
一般的な説明Orphenadrine citrate, N,Ndimethyl-2-(o-methyl-α-phenylbenzyloxy)ethylamine citrate(1:1) (Norflex), introduced in 1957, is closely related todiphenhydramine structurally but has much lower antihistaminicactivity and much higher anticholinergic action.Likewise, it lacks the sedative effects characteristic ofdiphenhydramine. Pharmacological testing indicates that itis not primarily a peripherally acting anticholinergic becauseit has only weak effects on smooth muscle, on the eye,and on secretory glands. It does reduce voluntary musclespasm, however, by a central inhibitory action on cerebralmotor areas, a central effect similar to that of atropine.
現在のフィルター条件では反応記録がありません。
読み込み中…
4682-36-4、4724-58-7定義ChEBI: A citrate salt which comprises equimolar amounts of orphenadrine and citric acid.